Private Capital Management (Minnesota)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$960K Sell
5,150
-1,550
-23% -$275K 1.08% 19
2017
Q2
$1.15M Buy
6,700
+500
+8% +$81.3K 1.28% 11
2017
Q1
$1.02M Sell
6,200
-850
-12% -$141K 1.11% 17
2016
Q4
$1.03M Buy
7,050
+1,950
+38% +$293K 1.15% 17
2016
Q3
$851K Sell
5,100
-2,450
-32% -$414K 0.9% 29
2016
Q2
$1.15M Hold
7,550
1.14% 14
2016
Q1
$1.13M Buy
7,550
+2,900
+62% +$431K 1.04% 15
2015
Q4
$755K Buy
+4,650
New +$731K 0.7% 45

Other funds holding AMGN

Private Capital Management (Minnesota)'s AMGN Position: Q3 2017 in Review

Private Capital Management (Minnesota) reduced its Amgen (AMGN) stake by 23% in Q3 2017, selling an estimated $275K and leaving 5,150 shares worth $960K. The position accounts for 1.08% of the portfolio, ranked #19.

Private Capital Management (Minnesota) first reported a position in AMGN in Q4 2015 and has held it in 8 quarters since. The position peaked at $1.15M in Q2 2017. 1,606 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Private Capital Management (Minnesota) held 5,150 shares of Amgen worth $960K as of Q3 2017.
  • Private Capital Management (Minnesota) sold 1,550 Amgen shares in Q3 2017, an estimated $275K.
  • Amgen made up 1.08% of Private Capital Management (Minnesota)'s portfolio in Q3 2017, its #19 holding.
  • Private Capital Management (Minnesota) first reported a position in Amgen in Q4 2015 and has held it in 8 quarters since.
  • Private Capital Management (Minnesota)'s Amgen position peaked at $1.15M in Q2 2017.
  • 1,606 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Private Capital Management (Minnesota)'s 13F filing for Q3 2017, filed 26 Oct 2017.